Johnson & Johnson
JNJ
$248.43
$4.962.04%
NYSE
| 12/28/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 94.19B | 92.15B | 90.63B | 89.33B | 88.82B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.19B | 92.15B | 90.63B | 89.33B | 88.82B |
| Cost of Revenue | 29.97B | 29.06B | 28.53B | 27.78B | 27.04B |
| Gross Profit | 64.23B | 63.09B | 62.10B | 61.55B | 61.79B |
| SG&A Expenses | 23.13B | 22.74B | 22.21B | 21.91B | 21.95B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.76B | 67.51B | 67.73B | 66.60B | 66.22B |
| Operating Income | 26.43B | 24.64B | 22.90B | 22.73B | 22.60B |
| Income Before Tax | 32.58B | 31.50B | 27.35B | 26.60B | 16.69B |
| Income Tax Expenses | 5.78B | 6.38B | 4.69B | 4.79B | 2.62B |
| Earnings from Continuing Operations | 26.80K | 25.12K | 22.66K | 21.81K | 14.07K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.80B | 25.12B | 22.66B | 21.81B | 14.07B |
| EBIT | 26.43B | 24.64B | 22.90B | 22.73B | 22.60B |
| EBITDA | 33.94B | 32.02B | 30.36B | 30.03B | 29.94B |
| EPS Basic | 11.11 | 10.42 | 9.40 | 9.05 | 5.83 |
| Normalized Basic EPS | 7.05 | 6.62 | 6.31 | 6.35 | 6.29 |
| EPS Diluted | 11.05 | 10.36 | 9.35 | 8.99 | 5.79 |
| Normalized Diluted EPS | 7.01 | 6.58 | 6.28 | 6.32 | 6.24 |
| Average Basic Shares Outstanding | 9.66B | 9.65B | 9.65B | 9.65B | 9.65B |
| Average Diluted Shares Outstanding | 9.71B | 9.70B | 9.70B | 9.70B | 9.71B |
| Dividend Per Share | 5.14 | 5.08 | 5.02 | 4.96 | 4.91 |
| Payout Ratio | 46.19% | 48.70% | 53.34% | 54.76% | 84.05% |